by In2Pharma | Oct 20, 2025 | News
The Netherlands Recent updates to the Dutch Medicines Act (Geneesmiddelenwet) of 8 February 2007 have been published. This Act defines the composition and responsibilities of the Medicines Evaluation Board (MEB) and regulates the licensing of manufacturers,...
by In2Pharma | Feb 25, 2022 | News
Belgium On 03.02.2022, the Federal Parliament approved a law that adjusts the financing of the Federal Agency for Medicines and Health Products (FAMHP). This has been published in the Belgian Official Journal and will come into force soon. The law introduces new taxes...
by In2Pharma | Sep 25, 2019 | News
Belgium Article 3, 2 °, of the Law of April 7th 2019 on unavailability was suspended by the Constitutional Court on July 18th 2019. This judgment means that wholesaler-distributors are no longer limited to the distribution of medicines to pharmacies and other Belgian...
by In2Pharma | Jun 7, 2019 | News
Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...
